815618-98-5

Downstream Products

• 815619-40-0 [5-[[2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-6-hydroxy-2,6-dioxo-hexyl]-dimethyl-sulfonium bromide 
• 815619-71-7 [5-[[2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-6-hydroxy-2,6-dioxo-hexyl]-diethyl-sulfonium bromide 
• 815619-73-9 2-[[2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-5-oxo-6-(1,3,4,5-tetramethylimidazol-1-ium-2-yl)sulfanyl-hexanoic acid bromide 
• 1092077-67-2 C₂₄H₂₇BrN₂O₆ 
• 1449280-38-9 2-[[2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-6-(1,3-diethyl-4,5-dimethyl-imidazol-1-ium-2-yl)sulfanyl-5-oxo-hexanoic acid bromide 
• 1449280-44-7 2-[[2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-6-(1-benzyl-3,4,5-trimethyl-imidazol-3-ium-2-yl)sulfanyl-5-oxo-hexanoic acid bromide 
• 1449280-42-5 2-[[2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-5-oxo-6-(1,4,5-trimethyl-3-phenyl-imidazol-1-ium-2-yl)sulfanyl-hexanoic acid bromide 
• 1449280-46-9 2-[[2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-6-(1,3-dimethyl-4,5-dipropyl-imidazol-1-ium-2-yl)sulfanyl-5-oxo-hexanoic acid bromide 
• 1449280-40-3 2-[[2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-5-oxo-6-(1,4,5-trimethyl-3-propyl-imidazol-1-ium-2-yl)sulfanyl-hexanoic acid bromide 

Relevant academic research and scientific papers

Synthesis of potent water-soluble tissue transglutaminase inhibitors

Dipeptide-based sulfonium peptidylmethylketones derived from 6-diazo-5-oxo-l-norleucine (DON) have been investigated as potential water-soluble inhibitors of extracellular transglutaminase. The lead compounds were prepared in four steps and exhibited pote